Discover how upcoming US healthcare legislation in 2026 will reshape biotech investing. This comprehensive guide details regulatory shifts, market implications, and strategic considerations for savvy investors navigating this evolving landscape.

The 2026 Inflation Reduction Act significantly reshapes biotech drug pricing, influencing investment returns and strategic decisions within the pharmaceutical sector. Understanding these updates is crucial for stakeholders.